NDRI has partnered with Research!America to administer a poll of the public to gather interest and support of donation of organs and tissues. The poll findings presented strong support for organ and tissue donations to advance discovery, improve health, and save lives.
NDRI has been accepted as a participant in the poster session at the Society for Neuroscience 2019 annual conference in Chicago, IL from October 19-23. We will be presenting on advancing Alzheimer's disease and related dementias research via a multi-pronged human biospecimens collection initiatives.
The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation the biorepository of the National Disease Research Interchange (NDRI) in Philadelphia, PA based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. NDRI was first accredited by CAP in 2016. Accreditations occur every three years.
Congratulations to The Center for Organ Recovery and Education, otherwise known as CORE, as the recipient of the inaugural NDRI/AOPO Empowering Research and Discovery Award for Outstanding commitment to the advancement of research.
Robert (Bob) Zipperlen, CPA joined NDRI in the spring of 2019 as the Vice President of Administration & CFO.
Read NDRI's 2019 Research Nexus for an exciting update on programs and initiatives, and learn how NDRI investigators are accelerating scientific discoveries!
Pennsylvania Governor Tom Wolf has appointed Bill Leinweber, President and CEO of the National Disease Research Interchange (NDRI), to serve a five-year term as a member of the state’s Organ and Tissue Donation Advisory Committee.
David M. Albert J.D., Director of Strategy, Emerging Business & Venture Capital Group of Cozen O’Connor. Elected on November 2 to a three-year term, Albert will bring his experience and insight to the nation’s leading source of human organs, cells and tissues for research.
NDRI’s Board of Directors met on Friday, November 2, 2018 to review and approve the 2017 audited financial statements, filing of Form 990, year-to-date financial and programmatic performance and NDRI’s 2019 Budget. Our executive staff provided the Board with a detailed overview of our many successful projects and partnerships, and included an update on the current status of NIH appropriations.
NDRI is very pleased to share that after eight years of advocacy efforts by the Center for Organ Recovery and Education (CORE) and the Gift of Life Donor Program of Philadelphia, lawmakers unanimously passed the Donate Life PA Act (SB 180) on Wednesday, October 10, 2018.
Bill Leinweber, President and CEO of National Disease Research Interchange (NDRI) admits that NDRI’s work is complicated, because medical research is complex. For nearly 40 years, NDRI has accepted the challenge of meeting increasing demands of the medical research community, who rely on high-quality, healthy, and diseased biospecimens to conduct lifesaving research.
The National Disease Research Interchange (NDRI) has been awarded more than $800,000 by the National Institutes of Health (NIH). The supplemental awards provide support for NDRI to serve as a human biospecimen resource for research focused specifically on Alzheimer’s disease, Autism Spectrum Disorder (ASD) and HIV/AIDS. The three awards are supplements to NDRI’s Human Tissues and Organs for Research Resources (HTORR) program which has been supported by the NIH since 1987.
“Support from the NIH affirms the strong value of our mission,” said Gene Kopen, PhD, NDRI’s Senior Vice President for Strategic Initiatives and principal investigator for the HTORR grant. “As an organization, NDRI has demonstrated the capacity to leverage this support to enable a broad range of complex research projects requiring human organs and tissues.”
The Board of Directors and staff of National Disease Research Interchange (NDRI) celebrate the extraordinary life and unparalleled legacy of
D. Walter Cohen, DDS, who died on June 29, 2018 in Philadelphia.
The 2018 Warren Alpert Foundation Prize has been awarded to five scientists for transformative discoveries in the fields of genetics, physiology, pulmonology and pharmacology that have led to the development of life-altering precision-targeted treatments for the devastating multiorgan disease cystic fibrosis (CF).
Read NDRI's 2018 Research Nexus for a recap of our Service to Science Awards Dinner, an exciting update on programs and initiatives, and learn how NDRI investigators are accelerating scientific discoveries!